The Omicron variant is rapidly becoming the dominant SARS-CoV-2 virus circulating
globally. It is important to define reductions in virus neutralizing activity in the serum of …

The respiratory system, especially the lung, is the key site of pathological injury induced by
SARS-CoV-2 infection. Given the low feasibility of targeted delivery of antibodies into the …

Recent reports of SARS-CoV-2 Omicron variant sub-lineages, BA. 1, BA. 1.1, and BA. 2,
have reignited concern over potential escape from vaccine-and infection-induced immunity …

The rapid expansion of the COVID-19 pandemic has made the development of a SARS-CoV-
2 vaccine a global health and economic priority. Taking advantage of versatility and rapid …

Neutralizing antibody responses gradually wane against several variants of concern (VOCs)
after vaccination with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The rapid spread of the highly contagious Omicron variant of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike …

The emergence of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs)
with decreased susceptibility to neutralization has generated interest in assessments of …

Since emergence of the initial SARS-CoV-2 BA. 1, BA. 2 and BA. 5 variants, Omicron has
diversified substantially. Antigenic characterization of these new variants is important to …

Abstract The Omicron SARS‐CoV‐2 variant was potentially generated from a chronically
infected COVID‐19 patient vaccinated with an messenger RNA (mRNA)‐or non‐mRNA …

Background Highly efficacious vaccines against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed. However, the emergence of viral …